Dermatopharmacokinetic Trial of LEO 80185 Gel
NCT02605057
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
32
Enrollment
INDUSTRY
Sponsor class
Conditions
Psoriasis Vulgaris
Interventions
DRUG:
LEO 80185 gel
DRUG:
Dovobet(r) Ointment
Sponsor
LEO Pharma